ZimVie Shareholders Approve ARCHIMED Acquisition
ZimVie Acquisition Approval: ZimVie Inc. stockholders approved the acquisition by an affiliate of ARCHIMED during a special meeting on October 10, 2025, with the merger expected to close on October 20, 2025, pending all conditions being met.
About ZimVie: ZimVie is a global leader in the dental implant market, providing a range of products and solutions aimed at enhancing dental restoration and tooth replacement procedures.
About ARCHIMED: ARCHIMED is a healthcare-focused investment firm with a global presence, managing €8 billion across various funds and specializing in supporting healthcare businesses in areas such as MedTech and Biopharma.
Forward-Looking Statements Caution: The announcement includes forward-looking statements that are subject to risks and uncertainties, which could affect the completion and benefits of the proposed transaction.
About the author






